APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amifostine

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Selected research

Industry Growth & Trends

Global Amifostine Industry Growth and Trends Forecast to 2032

8 January 202695 pages

Choose your research edition.

Industry ResearchAmifostine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Amifostine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Amifostine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amifostine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Amifostine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Amifostine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amifostine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amifostine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amifostine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Amifostine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amifostine Market by Company

Clinigen

Sun Pharmaceutical

Taj Pharmaceuticals

Merro Pharmaceutical

Luye Pharma

Mingren Pharma

Amifostine Segment by Type

400mg/Dose

500mg/Dose

Amifostine Segment by Application

Head and Neck Cancer Adjuvant Therapy

Others

Amifostine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifostine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amifostine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifostine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Amifostine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 400mg/Dose Table 2. Major Company of 500mg/Dose Table 3. Global Amifostine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Amifostine Sales by Type (2021-2026) & (K Units) Table 5. Global Amifostine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Amifostine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Amifostine Sales Market Share in Value by Type (2021-2026) Table 8. Global Amifostine Price by Type (2021-2026) & (USD/Unit) Table 9. Global Amifostine Sales by Type (2027-2032) & (K Units) Table 10. Global Amifostine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Amifostine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Amifostine Sales Market Share in Value by Type (2027-2032) Table 13. Global Amifostine Price by Type (2027-2032) & (USD/Unit) Table 14. North America Amifostine Sales by Type (2021-2026) & (K Units) Table 15. North America Amifostine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Amifostine Sales by Type (2021-2026) & (K Units) Table 17. Europe Amifostine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Amifostine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Amifostine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Amifostine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Amifostine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Amifostine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Amifostine Sales by Type (2021-2026) & (US$ Million) Table 24. Amifostine Industry Trends Table 25. Amifostine Industry Drivers Table 26. Amifostine Industry Opportunities and Challenges Table 27. Amifostine Industry Restraints Table 28. Global Amifostine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Amifostine Revenue Market Share by Company (2021-2026) Table 30. Global Amifostine Sales by Company (2021-2026) & (K Units) Table 31. Global Amifostine Sales Share by Company (2021-2026) Table 32. Global Amifostine Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Amifostine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Amifostine Major Company Production Sites and Headquarters Table 35. Global Amifostine Company, Product Type & Application Table 36. Global Amifostine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Amifostine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Amifostine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Amifostine Sales by Region (2021-2026) & (K Units) Table 41. Global Amifostine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Amifostine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Amifostine Sales Market Share in Value by Region (2021-2026) Table 44. Global Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Amifostine Sales by Region (2027-2032) & (K Units) Table 46. Global Amifostine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Amifostine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Amifostine Sales Market Share in Value by Region (2027-2032) Table 49. Global Amifostine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Amifostine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Amifostine Sales by Application (2021-2026) & (K Units) Table 52. Global Amifostine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Amifostine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Amifostine Sales Market Share in Value by Application (2021-2026) Table 55. Global Amifostine Price by Application (2021-2026) & (USD/Unit) Table 56. Global Amifostine Sales by Application (2027-2032) & (K Units) Table 57. Global Amifostine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Amifostine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Amifostine Sales Market Share in Value by Application (2027-2032) Table 60. Global Amifostine Price by Application (2027-2032) & (USD/Unit) Table 61. North America Amifostine Sales by Application (2021-2026) & (K Units) Table 62. North America Amifostine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Amifostine Sales by Application (2021-2026) & (K Units) Table 64. Europe Amifostine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Amifostine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Amifostine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Amifostine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Amifostine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Amifostine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Amifostine Sales by Application (2021-2026) & (US$ Million) Table 71. Clinigen Company Information Table 72. Clinigen Business Overview Table 73. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Clinigen Amifostine Product Portfolio Table 75. Clinigen Recent Development Table 76. Sun Pharmaceutical Company Information Table 77. Sun Pharmaceutical Business Overview Table 78. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Sun Pharmaceutical Amifostine Product Portfolio Table 80. Sun Pharmaceutical Recent Development Table 81. Taj Pharmaceuticals Company Information Table 82. Taj Pharmaceuticals Business Overview Table 83. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Taj Pharmaceuticals Amifostine Product Portfolio Table 85. Taj Pharmaceuticals Recent Development Table 86. Merro Pharmaceutical Company Information Table 87. Merro Pharmaceutical Business Overview Table 88. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Merro Pharmaceutical Amifostine Product Portfolio Table 90. Merro Pharmaceutical Recent Development Table 91. Luye Pharma Company Information Table 92. Luye Pharma Business Overview Table 93. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Luye Pharma Amifostine Product Portfolio Table 95. Luye Pharma Recent Development Table 96. Mingren Pharma Company Information Table 97. Mingren Pharma Business Overview Table 98. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Mingren Pharma Amifostine Product Portfolio Table 100. Mingren Pharma Recent Development Table 101. North America Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Amifostine Sales by Country (2021-2026) & (K Units) Table 103. North America Amifostine Sales Market Share by Country (2021-2026) Table 104. North America Amifostine Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Amifostine Sales Market Share Forecast by Country (2027-2032) Table 106. North America Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Amifostine Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Amifostine Market Share by Country (2021-2026) Table 109. North America Amifostine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Amifostine Market Share Forecast by Country (2027-2032) Table 111. Europe Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Amifostine Sales by Country (2021-2026) & (K Units) Table 113. Europe Amifostine Sales Market Share by Country (2021-2026) Table 114. Europe Amifostine Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Amifostine Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Amifostine Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Amifostine Market Share by Country (2021-2026) Table 119. Europe Amifostine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Amifostine Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Amifostine Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Amifostine Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Amifostine Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Amifostine Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Amifostine Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Amifostine Market Share by Country (2021-2026) Table 129. Asia-Pacific Amifostine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Amifostine Market Share Forecast by Country (2027-2032) Table 131. Latin America Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Amifostine Sales by Country (2021-2026) & (K Units) Table 133. Latin America Amifostine Sales Market Share by Country (2021-2026) Table 134. Latin America Amifostine Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Amifostine Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Amifostine Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Amifostine Market Share by Country (2021-2026) Table 139. Latin America Amifostine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Amifostine Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Amifostine Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Amifostine Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Amifostine Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Amifostine Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Amifostine Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Amifostine Market Share by Country (2021-2026) Table 149. Middle East and Africa Amifostine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Amifostine Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Amifostine Distributors List Table 154. Amifostine Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Amifostine Image Figure 2. Global Amifostine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amifostine Market Size (2021-2032) & (US$ Million) Figure 4. Global Amifostine Sales (2021-2032) & (K Units) Figure 5. 400mg/Dose Image Figure 6. Global 400mg/Dose Sales YoY Growth (2021-2032) & (K Units) Figure 7. 500mg/Dose Image Figure 8. Global 500mg/Dose Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Amifostine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Amifostine Market Share by Type 2025 VS 2032 Figure 11. North America Amifostine Sales Market Share in Volume by Type in 2025 Figure 12. North America Amifostine Sales Market Share in Value by Type in 2025 Figure 13. Europe Amifostine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Amifostine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Amifostine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Amifostine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Amifostine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Amifostine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Amifostine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Amifostine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Amifostine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Head and Neck Cancer Adjuvant Therapy Image Figure 24. Global Head and Neck Cancer Adjuvant Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Amifostine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Amifostine Market Share by Application 2025 VS 2032 Figure 29. North America Amifostine Sales Market Share in Volume by Application in 2025 Figure 30. North America Amifostine Sales Market Share in Value by Application in 2025 Figure 31. Europe Amifostine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Amifostine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Amifostine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Amifostine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Amifostine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Amifostine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Amifostine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Amifostine Sales Market Share in Value by Application in 2025 Figure 39. North America Amifostine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Amifostine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Amifostine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Amifostine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Amifostine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Amifostine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Amifostine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Amifostine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Amifostine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Amifostine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Amifostine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Amifostine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Amifostine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Amifostine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Amifostine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Amifostine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Amifostine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Amifostine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Amifostine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Amifostine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Amifostine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Amifostine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 400mg/Dose
  • 500mg/Dose
Applications
  • Head and Neck Cancer Adjuvant Therapy
  • Others
Companies covered
  • Clinigen
  • Sun Pharmaceutical
  • Taj Pharmaceuticals
  • Merro Pharmaceutical
  • Luye Pharma
  • Mingren Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amifostine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Amifostine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Amifostine Market by Type
  6. 1.3.1 400mg/Dose
  7. 1.3.2 500mg/Dose
  8. 1.4 Global Amifostine Market Size by Type
  9. 1.4.1 Global Amifostine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Amifostine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Amifostine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Amifostine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Amifostine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Amifostine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Amifostine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Amifostine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Amifostine Industry Trends
  2. 2.2 Amifostine Industry Drivers
  3. 2.3 Amifostine Industry Opportunities and Challenges
  4. 2.4 Amifostine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Amifostine Revenue (2021-2026)
  2. 3.2 Global Top Players by Amifostine Sales (2021-2026)
  3. 3.3 Global Top Players by Amifostine Price (2021-2026)
  4. 3.4 Global Amifostine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amifostine Major Company Production Sites & Headquarters
  6. 3.6 Global Amifostine Company, Product Type & Application
  7. 3.7 Global Amifostine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amifostine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amifostine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amifostine Tier 1, Tier 2, and Tier 3
4 Amifostine Regional Status and Outlook
  1. 4.1 Global Amifostine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Amifostine Historic Market Size by Region
  3. 4.2.1 Global Amifostine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Amifostine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Amifostine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Amifostine Forecasted Market Size by Region
  7. 4.3.1 Global Amifostine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Amifostine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Amifostine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amifostine by Application
  1. 5.1 Amifostine Market by Application
  2. 5.1.1 Head and Neck Cancer Adjuvant Therapy
  3. 5.1.2 Others
  4. 5.2 Global Amifostine Market Size by Application
  5. 5.2.1 Global Amifostine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Amifostine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Amifostine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Amifostine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Amifostine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Amifostine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Amifostine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Amifostine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Clinigen
  2. 6.1.1 Clinigen Company Information
  3. 6.1.2 Clinigen Business Overview
  4. 6.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Clinigen Amifostine Product Portfolio
  6. 6.1.5 Clinigen Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Amifostine Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Taj Pharmaceuticals
  14. 6.3.1 Taj Pharmaceuticals Company Information
  15. 6.3.2 Taj Pharmaceuticals Business Overview
  16. 6.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
  18. 6.3.5 Taj Pharmaceuticals Recent Developments
  19. 6.4 Merro Pharmaceutical
  20. 6.4.1 Merro Pharmaceutical Company Information
  21. 6.4.2 Merro Pharmaceutical Business Overview
  22. 6.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merro Pharmaceutical Amifostine Product Portfolio
  24. 6.4.5 Merro Pharmaceutical Recent Developments
  25. 6.5 Luye Pharma
  26. 6.5.1 Luye Pharma Company Information
  27. 6.5.2 Luye Pharma Business Overview
  28. 6.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Luye Pharma Amifostine Product Portfolio
  30. 6.5.5 Luye Pharma Recent Developments
  31. 6.6 Mingren Pharma
  32. 6.6.1 Mingren Pharma Company Information
  33. 6.6.2 Mingren Pharma Business Overview
  34. 6.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mingren Pharma Amifostine Product Portfolio
  36. 6.6.5 Mingren Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Amifostine Sales by Country
  2. 7.1.1 North America Amifostine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Amifostine Sales by Country (2021-2026)
  4. 7.1.3 North America Amifostine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Amifostine Market Size by Country
  6. 7.2.1 North America Amifostine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Amifostine Market Size by Country (2021-2026)
  8. 7.2.3 North America Amifostine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Amifostine Sales by Country
  2. 8.1.1 Europe Amifostine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Amifostine Sales by Country (2021-2026)
  4. 8.1.3 Europe Amifostine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Amifostine Market Size by Country
  6. 8.2.1 Europe Amifostine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Amifostine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Amifostine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Amifostine Sales by Country
  2. 9.1.1 Asia-Pacific Amifostine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Amifostine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Amifostine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Amifostine Market Size by Country
  6. 9.2.1 Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Amifostine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Amifostine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Amifostine Sales by Country
  2. 10.1.1 South America Amifostine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Amifostine Sales by Country (2021-2026)
  4. 10.1.3 South America Amifostine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Amifostine Market Size by Country
  6. 10.2.1 South America Amifostine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Amifostine Market Size by Country (2021-2026)
  8. 10.2.3 South America Amifostine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Amifostine Sales by Country
  2. 11.1.1 Middle East and Africa Amifostine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Amifostine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Amifostine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Amifostine Market Size by Country
  6. 11.2.1 Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Amifostine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Amifostine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Amifostine Value Chain Analysis
  2. 12.1.1 Amifostine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Amifostine Production Mode & Process
  7. 12.2 Amifostine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Amifostine Distributors
  10. 12.2.3 Amifostine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst